Return to previous pagePrint page

Go Back Go Back
Name Related Structures Hours Description
19. Lymphadenopathy, Splenomegaly, and Cancer - Lecture Results
Related Results
Approach to Lymphadenopathy and SplenomegalyClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Breast DiseaseClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Breast Disease PathologyClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Cancer, Genetics, DNA Integrity and RepairClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer2
Childhood CancersClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Introduction to Adult CancerClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1.5
Pathology and Laboratory Diagnosis of LymphomaClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Pathology of LymphomaClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1Laboratory Diagnosis of Lymphoma
Pediatric Cancer PathologyClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
PharmacogenomicsClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Tumor ImmunologyClass of 2023, Phase 3, 7710 - The Patient III, 19. Lymphadenopathy, Splenomegaly, and Cancer1
Name Related Structures Hours Description
Results:11